BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30357400)

  • 1. Induction of Apoptosis in Pterygium Cells by Antagonists of Growth Hormone-Releasing Hormone Receptors.
    Qin YJ; Chu WK; Huang L; Ng CHY; Chan TCY; Cao D; Yang C; Zhang L; Huang SP; Li J; Lin HL; Li WQ; Chen L; Schally AV; Chan SO; Zhang HY; Pang CP
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5060-5066. PubMed ID: 30357400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.
    Chu WK; Law KS; Chan SO; Yam JC; Chen LJ; Zhang H; Cheung HS; Block NL; Schally AV; Pang CP
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14396-14401. PubMed ID: 27911838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
    Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
    Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).
    Kanashiro-Takeuchi RM; Takeuchi LM; Rick FG; Dulce R; Treuer AV; Florea V; Rodrigues CO; Paulino EC; Hatzistergos KE; Selem SM; Gonzalez DR; Block NL; Schally AV; Hare JM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):559-63. PubMed ID: 22203988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
    Jimenez JJ; DelCanto GM; Popovics P; Perez A; Vila Granda A; Vidaurre I; Cai RZ; Rick FG; Swords RT; Schally AV
    Br J Haematol; 2018 May; 181(4):476-485. PubMed ID: 29663325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Axis of GHRH and GHRH Receptor on Cell Viability and Apoptosis of the Placental Choriocarcinoma Cell Line.
    Liu AX; Zhang D; Zhu YM; Gao HJ; Jiang JY; Hu XL; Lv PP; Leung PC; Huang HF
    Curr Mol Med; 2016; 16(3):299-311. PubMed ID: 26917260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer.
    Muñoz-Moreno L; Schally AV; Prieto JC; Carmena MJ; Bajo AM
    Prostate; 2018 Sep; 78(12):915-926. PubMed ID: 29748961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation.
    Liang WC; Ren JL; Yu QX; Li J; Ng TK; Chu WK; Qin YJ; Chu KO; Schally AV; Pang CP; Chan SO
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6067-6074. PubMed ID: 32123064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
    Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
    Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
    Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
    Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation.
    Qin YJ; Chan SO; Chong KK; Li BF; Ng TK; Yip YW; Chen H; Zhang M; Block NL; Cheung HS; Schally AV; Pang CP
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18303-8. PubMed ID: 25489106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
    Pozsgai E; Schally AV; Zarandi M; Varga JL; Vidaurre I; Bellyei S
    Int J Cancer; 2010 Nov; 127(10):2313-22. PubMed ID: 20162575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling.
    Gan J; Ke X; Jiang J; Dong H; Yao Z; Lin Y; Lin W; Wu X; Yan S; Zhuang Y; Chu WK; Cai R; Zhang X; Cheung HS; Block NL; Pang CP; Schally AV; Zhang H
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14745-14750. PubMed ID: 27930339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.
    Cen LP; Ng TK; Liang JJ; Xu C; Zhuang X; Liu YF; Chen SL; Xu Y; Yang Q; Yuan XL; Qin YJ; Chan SO; Chen H; Zhang M; Schally AV; Pang CP
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
    Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
    Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor.
    Rodríguez-Pacheco F; Gutierrez-Repiso C; García-Serrano S; Ho-Plagaro A; Gómez-Zumaquero JM; Valdes S; Gonzalo M; Rivas-Becerra J; Montiel-Casado C; Rojo-Martínez G; García-Escobar E; García-Fuentes E
    Int J Obes (Lond); 2017 Oct; 41(10):1547-1555. PubMed ID: 28626214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of endogenous growth hormone-releasing hormone receptors dissociates nocturnal growth hormone secretion and slow-wave sleep.
    Jessup SK; Malow BA; Symons KV; Barkan AL
    Eur J Endocrinol; 2004 Nov; 151(5):561-6. PubMed ID: 15538933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.